Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

GARY LEE JOHNSON

Allopathic & Osteopathic Physicians Family Medicine

NPI
1750300430
CMS profile
170731
Location
MADISON, WI

General Payments · PY2018–2023

$238,828.78

  • Reported across 263 records
  • CMS publication 2026-01-23

Latest program year · PY2023

$49,243.06

37 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2023 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $42,139.50 10
Travel and Lodging $6,241.38 17
Food and Beverage $862.18 10

By paying entity

PY2023 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $77,217.11 101
PY2019 $70,579.14 87
PY2020 $17,077.59 9
PY2021 $14,459.00 13
PY2022 $10,252.88 16
PY2023 $49,243.06 37

Payment records · PY2023 (37)

Sorted by paying entity, then date · as published by CMS

Program year 2023 20182019202020212022 Record-level detail is published for PY2023; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Boehringer Ingelheim Pharmaceuticals, Inc. $2,226.00 10/17/2023 Consulting Fee Undisputed 01/23/2026 997027173 CMS
E.R. Squibb & Sons, L.L.C. $303.97 01/27/2023 Travel and Lodging Undisputed 01/23/2026 1015305949 CMS
E.R. Squibb & Sons, L.L.C. $3,096.00 03/01/2023 Consulting Fee Undisputed 01/23/2026 1015305401 CMS
EMD Serono, Inc. $7,290.00 03/28/2023 Consulting Fee Undisputed 01/23/2026 1052754417 CMS
EMD Serono, Inc. $4,050.00 05/30/2023 Consulting Fee Undisputed 01/23/2026 1052753133 CMS
Genentech USA, Inc. $238.26 09/15/2023 Travel and Lodging Undisputed 01/23/2026 1040366975 CMS
Genentech USA, Inc. $3,030.00 09/15/2023 Consulting Fee Undisputed 01/23/2026 1040366982 CMS
Genentech USA, Inc. $488.63 09/15/2023 Travel and Lodging Undisputed 01/23/2026 1040366987 CMS
Genentech USA, Inc. $32.00 12/10/2023 Travel and Lodging Undisputed 01/23/2026 1040366993 CMS
Genentech USA, Inc. $504.13 12/10/2023 Travel and Lodging Undisputed 01/23/2026 1040366999 CMS
Genentech USA, Inc. $303.97 12/10/2023 Travel and Lodging Undisputed 01/23/2026 1040367005 CMS
Genentech USA, Inc. $4,415.00 12/10/2023 Consulting Fee Undisputed 01/23/2026 1040367011 CMS
Genentech, Inc. $4,920.00 04/13/2023 Consulting Fee Undisputed 01/23/2026 1040367023 CMS
Genentech, Inc. $141.18 04/13/2023 Food and Beverage Undisputed 01/23/2026 1040367029 CMS
Genentech, Inc. $583.11 04/13/2023 Travel and Lodging Undisputed 01/23/2026 1040367035 CMS
Genentech, Inc. $73.95 04/13/2023 Travel and Lodging Undisputed 01/23/2026 1040367041 CMS
Genentech, Inc. $607.94 04/13/2023 Travel and Lodging Undisputed 01/23/2026 1040367047 CMS
Genentech, Inc. $219.83 04/14/2023 Food and Beverage Undisputed 01/23/2026 1040367017 CMS
ITI, Inc. $4,500.00 06/01/2023 Consulting Fee Undisputed 01/23/2026 1040575639 CMS
ITI, Inc. $381.94 06/01/2023 Travel and Lodging Undisputed 01/23/2026 1040575648 CMS
ITI, Inc. $90.00 06/01/2023 Food and Beverage Undisputed 01/23/2026 1040575655 CMS
ITI, Inc. $451.43 06/01/2023 Travel and Lodging Undisputed 01/23/2026 1040575665 CMS
ITI, Inc. $595.21 06/01/2023 Travel and Lodging Undisputed 01/23/2026 1040575669 CMS
NOVARTIS PHARMACEUTICALS CORPORATION $4,112.50 09/09/2023 Consulting Fee Undisputed 01/23/2026 993441687 CMS
NOVARTIS PHARMACEUTICALS CORPORATION $155.46 09/09/2023 Food and Beverage Undisputed 01/23/2026 993441689 CMS
NOVARTIS PHARMACEUTICALS CORPORATION $20.87 09/09/2023 Food and Beverage Undisputed 01/23/2026 993441691 CMS
NOVARTIS PHARMACEUTICALS CORPORATION $237.38 09/09/2023 Travel and Lodging Undisputed 01/23/2026 993441737 CMS
NOVARTIS PHARMACEUTICALS CORPORATION $150.43 09/09/2023 Travel and Lodging Undisputed 01/23/2026 993441739 CMS
NOVARTIS PHARMACEUTICALS CORPORATION $32.00 09/09/2023 Travel and Lodging Undisputed 01/23/2026 993441741 CMS
Pharmacyclics LLC, An AbbVie Company $351.03 09/19/2023 Travel and Lodging Undisputed 01/23/2026 998287825 CMS
Pharmacyclics LLC, An AbbVie Company $101.81 09/19/2023 Food and Beverage Undisputed 01/23/2026 998287827 CMS
Pharmacyclics LLC, An AbbVie Company $10.18 09/20/2023 Food and Beverage Undisputed 01/23/2026 998287829 CMS
Pharmacyclics LLC, An AbbVie Company $906.00 09/20/2023 Travel and Lodging Undisputed 01/23/2026 998287831 CMS
Pharmacyclics LLC, An AbbVie Company $58.37 09/20/2023 Food and Beverage Undisputed 01/23/2026 998287833 CMS
Pharmacyclics LLC, An AbbVie Company $54.30 09/20/2023 Food and Beverage Undisputed 01/23/2026 998287835 CMS
Pharmacyclics LLC, An AbbVie Company $10.18 09/20/2023 Food and Beverage Undisputed 01/23/2026 998287837 CMS
ViiV Healthcare Company $4,500.00 12/08/2023 Consulting Fee Undisputed 01/23/2026 1061287261 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023
Generated from
OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.